SCHEMBL6862764

SCHEMBL6862764

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
P2RX7 Q99572 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
ABCB1 P08183 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34
CNR2 P34972 3/20 0.33
ALDH1A1 P00352 2/20 0.32
P2RX4 Q99571 2/20 0.32
CNR1 P21554 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
DRD2 P14416 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713260 0.88 P2RX4 (0.41) MEN1KMT2ANPSR1P2RX7SMN1; SMN2
SCHEMBL6707989 0.88 NPSR1 (0.39) MEN1KMT2ANPSR1P2RX7SMN1; SMN2
SCHEMBL6707765 0.87 MAP3K5 (0.34) KMT2ALMNARXFP1TP53MAP3K5
SCHEMBL6707720 0.86 MEN1 (0.36) MEN1KMT2ANPSR1P2RX7SMN1; SMN2
SCHEMBL6709971 0.85 GSK3B (0.40) RXFP1KDM4ETP53DRD2DRD3
SCHEMBL6710380 0.85 MAP3K5 (0.43) MEN1KMT2ANPC1LMNARAB9A
SCHEMBL6710250 0.85 KMT2A (0.42) MEN1KMT2ANPC1RAB9AABCG2
SCHEMBL6710254 0.84 NPC1 (0.40) SMN1; SMN2NPC1LMNARAB9ADRD2
SCHEMBL6709197 0.84 IRAK4 (0.42) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL6709998 0.84 GSK3B (0.37) KMT2ASMN1; SMN2NPC1RAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MEN1 4100/4885KMT2A 3181/4885NPSR1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.